Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000376591 | SCV000402736 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000284460 | SCV000402737 | uncertain significance | Naxos disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000478371 | SCV000565086 | likely benign | not specified | 2016-03-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002061226 | SCV002466679 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000478371 | SCV003928534 | benign | not specified | 2023-04-26 | criteria provided, single submitter | clinical testing |